Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by RFG Advisory LLC

RFG Advisory LLC decreased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,699 shares of the biotechnology company’s stock after selling 390 shares during the period. RFG Advisory LLC’s holdings in Axon Enterprise were worth $1,604,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Dimensional Fund Advisors LP boosted its holdings in Axon Enterprise by 10.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 186,473 shares of the biotechnology company’s stock valued at $54,874,000 after purchasing an additional 17,905 shares in the last quarter. AE Wealth Management LLC boosted its stake in shares of Axon Enterprise by 24.8% in the second quarter. AE Wealth Management LLC now owns 831 shares of the biotechnology company’s stock valued at $245,000 after buying an additional 165 shares in the last quarter. Public Sector Pension Investment Board grew its holdings in Axon Enterprise by 79.5% during the second quarter. Public Sector Pension Investment Board now owns 2,604 shares of the biotechnology company’s stock worth $766,000 after acquiring an additional 1,153 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its holdings in Axon Enterprise by 61.5% during the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 13,730 shares of the biotechnology company’s stock worth $4,040,000 after acquiring an additional 5,230 shares during the period. Finally, MBB Public Markets I LLC purchased a new position in Axon Enterprise in the second quarter worth $1,412,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on AXON shares. Northland Securities upped their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. JMP Securities boosted their price target on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Robert W. Baird raised their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, The Goldman Sachs Group boosted their target price on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $504.92.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $610.32 on Friday. Axon Enterprise, Inc. has a 12-month low of $247.04 and a 12-month high of $698.67. The firm has a market cap of $46.54 billion, a price-to-earnings ratio of 157.71, a price-to-earnings-growth ratio of 6.09 and a beta of 1.04. The company’s 50-day moving average is $617.65 and its two-hundred day moving average is $470.75. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the sale, the director now directly owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 50,545 shares of company stock valued at $30,721,337. Company insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.